Pilot study of interferon-α–ribavirin–interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1
✍ Scribed by L. Alric; S. Thebault; J.-M. Peron; P. Balard; S. Metivier; B. Pipy; J. Izopet; J.-P. Vinel
- Book ID
- 108885853
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 153 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We read with great interest the recent report by Li et al. 1 analyzing the correlation between the clusters of differentiation 24 (CD24) polymorphism and risk of chronic hepatitis B virus (HBV) infection. In their study, the CD24 P170 T allele (thymidine at position 170) was correlated with a strong
## Abstract An investigation was carried out to determine whether early viral monitoring could predict efficiently the virological response to combination therapy of two different regimens in treatment‐naïve chronic hepatitis C patients infected with genotype 1b with high baseline viral load. Patie